Sector
PharmaceuticalsOpen
₹772Prev. Close
₹779.25Turnover(Lac.)
₹22.85Day's High
₹794.95Day's Low
₹77252 Week's High
₹934.9552 Week's Low
₹383Book Value
₹95.11Face Value
₹10Mkt Cap (₹ Cr.)
1,007.68P/E
35.58EPS
21.9Divi. Yield
021 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
30 May 2023
12:00 AM
Dividend
Dividend Amount: 0.5
Record Date: 07 Sep, 2023
25 Aug 2023
12:00 AM
AGM
Announcement Date: 25 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 12.51 | 12.01 | 10.01 | 8.97 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 76.43 | 49.57 | 40 | 33.12 |
Net Worth | 88.94 | 61.58 | 50.01 | 42.09 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 49.07 | 58.42 | 27.26 | 19.85 |
yoy growth (%) | -16 | 114.31 | 37.27 | 27.95 |
Raw materials | -22.01 | -35.59 | -14.91 | -10.03 |
As % of sales | 44.86 | 60.92 | 54.7 | 50.53 |
Employee costs | -3.84 | -3.26 | -2.36 | -1.86 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 12.94 | 12.74 | 6.47 | 3.94 |
Depreciation | -2.72 | -2.24 | -0.59 | -0.54 |
Tax paid | -3.19 | -3.11 | -1.78 | -1.3 |
Working capital | 4.53 | 0.28 | 7.9 | 2.61 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -16 | 114.31 | 37.27 | 27.95 |
Op profit growth | 24.67 | 110.98 | 27.57 | 110.71 |
EBIT growth | 1.02 | 95.9 | 64.91 | 136.73 |
Net profit growth | 1.34 | 105.33 | 77.66 | 141.17 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Gross Sales | 125.9 | 49.08 | 64.02 | 35.31 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 125.9 | 49.08 | 64.02 | 35.31 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 3.07 | 2.09 | 3.91 | 1.17 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Chandubhai Kothia
Whole-time Director
Gunjan Chandulal Kothia
Whole-time Director
Parth Chandulal Kothia
Independent Director
Priyam Surendra Shah
Independent Director
Jayesh Savjani
Independent Director
Vaishaliben Kanjibhai Vadodariya
Director
Parul Sahani
Independent Director
Maulikkumar Sudani
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Shree Ganesh Remedies Ltd
Summary
Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name Shree Ganesh Remedies Private Limited at Ahmedabad, Gujarat on April 27, 1995. Subsequently the Company was converted into a Public Limited and the name of the Company was changed to Shree Ganesh Remedies Limited on July 28, 2017. The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals.Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Products are manufactured for export market and also for domestic and foreign markets. The Company entered the International market in 2006 and are on regular basis exporting its products to various countries.The manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across 9715 square meters having different product manufacturing capabilities and process. The manufacturing process is supported by Total Quality Management techniques and is supervised through various quality control equipments and qualified personnel. The Products are manufactured for export mark
Read More
What is the Shree Ganesh Remedies Ltd share price today?
The Shree Ganesh Remedies Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹785 today.
What is the Market Cap of Shree Ganesh Remedies Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shree Ganesh Remedies Ltd is ₹1007.68 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Shree Ganesh Remedies Ltd?
The PE and PB ratios of Shree Ganesh Remedies Ltd is 35.58 and 8.19 as of 22 Jul ‘24
What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?
The 52-week high/low is the highest and lowest price at which a Shree Ganesh Remedies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Shree Ganesh Remedies Ltd is ₹383 and ₹934.95 as of 22 Jul ‘24
What is the CAGR of Shree Ganesh Remedies Ltd?
Shree Ganesh Remedies Ltd's CAGR for 5 Years at 76.12%, 3 Years at 31.94%, 1 Year at 99.42%, 6 Month at 13.05%, 3 Month at 27.68% and 1 Month at -5.93%.
What is the shareholding pattern of Shree Ganesh Remedies Ltd?
The shareholding pattern of Shree Ganesh Remedies Ltd is as follows:
Promoters - 69.35 %
Institutions - 0.01 %
Public - 30.65 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
